These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 646105)

  • 1. Determination of the normality of cholinesterase solutions.
    Gordon MA; Carpenter DE; Barrett HW; Wilson IB
    Anal Biochem; 1978 Apr; 85(2):519-27. PubMed ID: 646105
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of normality of acetylcholinesterase.
    Suszkiw JB
    Anal Biochem; 1971 Nov; 44(1):321-4. PubMed ID: 5132848
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of 1-methyl-acylquinolinium iodides for assaying acetylcholinesterase in tissue homogenates--differentiation between acetylcholinesterase and cholinesterase.
    Voorhorst CD
    Biochem Pharmacol; 1971 Jun; 20(6):1321-3. PubMed ID: 5118127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticholinesterase properties of benzo(f)quinolinium derivatives].
    Kuleshov VI; Kozlov NS; Libman NM; Kosmacheva IM; Zhikhareva OD
    Biokhimiia; 1981 Oct; 46(10):1764-7. PubMed ID: 7306595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro properties of a powerful quaternary methylphosphonate inhibitor of acetylcholinesterase. A new marker in blood-brain barrier research.
    Levy D; Ashani Y
    Biochem Pharmacol; 1986 Apr; 35(7):1079-85. PubMed ID: 3754444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New re-activators of acetylcholinesterase. I. Quinoliniumphenacylchloride oxime].
    Malatesta P; Quaglia G; La Floresta E
    Farmaco Sci; 1968 Aug; 23(8):757-64. PubMed ID: 5670115
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the molar concentration of acetylcholinesterase based on phosphorylation by paraoxon or soman].
    Nenner M
    Biochim Biophys Acta; 1971 Aug; 242(2):371-80. PubMed ID: 5160151
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorescent probes of acetylcholinesterase.
    Mooser G; Schulman H; Sigman DS
    Biochemistry; 1972 Apr; 11(9):1595-602. PubMed ID: 5063708
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
    Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of catalysis by acetylcholinesterase. I. Fluorescent titration with a carbamoylating agent.
    Rosenberry TL; Bernhard SA
    Biochemistry; 1971 Oct; 10(22):4114-20. PubMed ID: 5168614
    [No Abstract]   [Full Text] [Related]  

  • 11. The reaction of acetylcholinesterase with O-dimethylcarbamyl esters of quaternary quinolinium compounds.
    Kitz RJ; Ginsburg S; Wilson IB
    Biochem Pharmacol; 1967 Nov; 16(11):2201-9. PubMed ID: 6076610
    [No Abstract]   [Full Text] [Related]  

  • 12. Torpedo acetylcholinesterase is inactivated by thiol reagents.
    Steinberg N; Roth E; Silman I
    Biochem Int; 1990 Sep; 21(6):1043-50. PubMed ID: 1964378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a modifier site on acetylcholinesterase with affinity for d-tubocurarine.
    Mooser G; Sigman DS
    Biochem Biophys Res Commun; 1972 Aug; 48(3):559-64. PubMed ID: 5065402
    [No Abstract]   [Full Text] [Related]  

  • 14. The reaction of acetylcholinesterase with methanesulfonyl esters of quaternary quinolinium compounds.
    Ryan JF; Ginsburg S; Kitz RJ
    Biochem Pharmacol; 1969 Feb; 18(2):269-78. PubMed ID: 5778146
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
    Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reaction of acetylcholinesterase (AChe) with some quaternary hydroxy aminophenols.
    Kitz RJ; Ginsburg S
    Biochem Pharmacol; 1968 Apr; 17(4):525-32. PubMed ID: 5690300
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of catalysis by acetylcholinesterase. Synergistic effects of inhibitors during the hydrolysis of acetic acid esters.
    Rosenberry TL; Bernhard SA
    Biochemistry; 1972 Nov; 11(23):4308-21. PubMed ID: 5079901
    [No Abstract]   [Full Text] [Related]  

  • 18. Ligand binding properties of acetylcholinesterase determined with fluorescent probes.
    Mooser G; Sigman DS
    Biochemistry; 1974 May; 13(11):2299-307. PubMed ID: 4857568
    [No Abstract]   [Full Text] [Related]  

  • 19. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
    Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
    Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinesterase activity of the unsymmetric bisquaternary 6-aminoquinoline salt NSC-176319.
    Hacker MP; Braddock J; Unwin S
    Biochem Pharmacol; 1982 Feb; 31(3):301-4. PubMed ID: 7073762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.